National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
NCI Drug Dictionary
Page Options
Print This Page  Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
Contains
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

ethinyl estradiol 
A semisynthetic estrogen. Ethinyl estradiol binds to the estrogen receptor complex and enters the nucleus, activating DNA transcription of genes involved in estrogenic cellular responses. This agent also inhibits 5-alpha reductase in epididymal tissue, which lowers testosterone levels and may delay progression of prostatic cancer. In addition to its antineoplastic effects, ethinyl estradiol protects against osteoporosis. In animal models, short-term therapy with this agent has been shown to provide long-term protection against breast cancer, mimicking the antitumor effects of pregnancy. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
US brand names:Estinyl
Ethinoral
Feminone
Orestralyn
Foreign brand names:Diogyn E
Eticylol
Inestra
Lynoral
Abbreviation:EE
Chemical structure name:(17alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov